Hippo (HIPO) Financials

$24.06 -0.27 (-1.11%)

As of 11:27 AM Eastern

Annual Income Statements for Hippo

This table shows Hippo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-371	-333	-273	-41
Consolidated Net Income / (Loss)	-368	-327	-263	-29
Net Income / (Loss) Continuing Operations	-169	-327	-263	-29
Total Pre-Tax Income	-367	-325	-263	-27
Total Operating Income	-215	-328	-263	-82
Total Gross Profit	-35	-42	-51	74
Total Revenue	91	120	210	372
Operating Revenue	91	120	210	372
Total Cost of Revenue	126	161	261	298
Operating Cost of Revenue	126	161	261	298
Total Operating Expenses	180	286	212	156
Selling, General & Admin Expense	49	72	80	71
Marketing Expense	95	102	80	51
Research & Development Expense	36	58	47	31
Restructuring Charge	0.00	55	5.50	3.60
Total Other Income / (Expense), net	47	0.00	0.00	54
Other Income / (Expense), net	-	0.00	0.00	54
Income Tax Expense	0.70	1.30	0.50	1.20
Net Income / (Loss) Attributable to Noncontrolling Interest	3.50	6.90	10	12
Basic Earnings per Share	($34.11)	($14.66)	($11.58)	($1.64)
Weighted Average Basic Shares Outstanding	10.89M	22.75M	23.58M	24.70M
Diluted Earnings per Share	($34.11)	($14.66)	($11.58)	($1.64)
Weighted Average Diluted Shares Outstanding	10.89M	22.75M	23.58M	24.70M
Weighted Average Basic & Diluted Shares Outstanding	566.27M	23.31M	24.31M	25.08M

This table shows Hippo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	9/30/2024
Net Income / (Loss) Attributable to Common Shareholders	-129	-63	-70	-108	-53	-42	-36	-8.50
Consolidated Net Income / (Loss)	-128	-61	-68	-105	-50	-39	-33	-5.20
Net Income / (Loss) Continuing Operations	-128	-61	-68	-105	-50	-39	-33	-5.20
Total Pre-Tax Income	-127	-60	-68	-105	-51	-39	-33	-5.20
Total Operating Income	-127	-61	-68	-105	-51	-40	-33	-5.20
Total Gross Profit	-8.80	-3.70	-14	-48	0.90	9.50	12	21
Total Revenue	31	36	40	48	58	65	85	96
Operating Revenue	31	36	40	48	58	65	85	96
Total Cost of Revenue	40	40	54	96	57	55	73	74
Operating Cost of Revenue	40	40	54	96	57	55	73	74
Total Operating Expenses	119	57	54	57	52	50	45	27
Selling, General & Admin Expense	19	18	20	22	21	18	18	15
Marketing Expense	29	28	22	23	19	16	14	13
Research & Development Expense	15	12	12	13	12	10	8.30	7.00
Other Operating Expenses / (Income)	-	-	-	0.00	0.00	-	-	-0.10
Restructuring Charge	55	-	0.00	0.00	0.00	5.50	3.60	0.00
Other Special Charges / (Income)	-	-	-	-	0.00	-	-	-8.20
Total Other Income / (Expense), net	0.10	-1.40	0.00	0.00	0.00	-	0.00	0.00
Income Tax Expense	0.30	0.50	0.30	0.20	-0.30	0.30	0.20	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	1.70	2.60	1.70	2.60	2.80	3.00	2.60	3.30
Basic Earnings per Share	($5.66)	($2.77)	($3.01)	($4.61)	($2.24)	($1.80)	($1.47)	($0.34)
Weighted Average Basic Shares Outstanding	22.84M	22.75M	23.20M	23.39M	23.73M	23.58M	24.23M	25.07M
Diluted Earnings per Share	($5.66)	($2.77)	($3.01)	($4.61)	($2.24)	($1.80)	($1.47)	($0.34)
Weighted Average Diluted Shares Outstanding	22.84M	22.75M	23.20M	23.39M	23.73M	23.58M	24.23M	25.07M
Weighted Average Basic & Diluted Shares Outstanding	23.06M	23.31M	23.26M	23.67M	23.89M	24.31M	24.43M	24.36M

This table details how cash moves in and out of Hippo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	326	-574	-49	38
Net Cash From Operating Activities	-125	-162	-92	48
Net Cash From Continuing Operating Activities	-125	-162	-92	48
Net Income / (Loss) Continuing Operations	-368	-327	-263	-29
Consolidated Net Income / (Loss)	-368	-327	-263	-29
Depreciation Expense	11	15	20	23
Non-Cash Adjustments To Reconcile Net Income	241	180	188	99
Changes in Operating Assets and Liabilities, net	-29	-30	-37	-46
Net Cash From Investing Activities	-30	-406	58	30
Net Cash From Continuing Investing Activities	-30	-406	58	30
Purchase of Property, Plant & Equipment	-14	-20	-47	-12
Purchase of Investments	-26	-793	-410	-368
Divestitures	-	0.00	0.00	73
Sale and/or Maturity of Investments	17	409	517	337
Other Investing Activities, net	-2.90	-2.00	-3.20	0.20
Net Cash From Financing Activities	481	-6.80	-15	-40
Net Cash From Continuing Financing Activities	481	-6.80	-15	-40
Repurchase of Common Equity	-	0.00	-1.80	-16
Payment of Dividends	-	-5.30	-9.60	-20
Issuance of Common Equity	-	4.10	2.80	6.70
Other Financing Activities, net	482	-5.60	-6.00	-11

This table details how cash moves in and out of Hippo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024
Net Change in Cash & Equivalents	68	-148	-24	18	31	-74	68	-43
Net Cash From Operating Activities	-43	-30	-36	-9.30	1.10	-49	18	-11
Net Cash From Continuing Operating Activities	-43	-30	-36	-9.30	1.10	-49	18	-11
Net Income / (Loss) Continuing Operations	-128	-61	-68	-105	-50	-39	-33	-37
Consolidated Net Income / (Loss)	-128	-61	-68	-105	-50	-39	-33	-37
Depreciation Expense	3.80	4.00	4.30	5.20	4.90	5.40	5.60	5.90
Non-Cash Adjustments To Reconcile Net Income	88	57	48	99	50	-8.80	59	33
Changes in Operating Assets and Liabilities, net	-7.50	-31	-20	-7.90	-3.80	-5.80	-14	-12
Net Cash From Investing Activities	113	-115	14	35	31	-22	59	-28
Net Cash From Continuing Investing Activities	113	-115	14	35	31	-22	59	-28
Purchase of Property, Plant & Equipment	-5.50	-3.50	-3.90	-34	-4.70	-4.50	-3.40	-3.80
Purchase of Investments	-237	-148	-111	-96	-84	-119	-55	-84
Sale and/or Maturity of Investments	355	36	130	165	119	104	117	60
Net Cash From Financing Activities	-1.10	-3.10	-1.90	-8.00	-0.90	-3.80	-8.00	-4.40
Net Cash From Continuing Financing Activities	-1.10	-3.10	-1.90	-8.00	-1.00	-3.70	-8.00	-4.40
Payment of Dividends	-	-3.10	-0.60	-5.80	-0.10	-3.10	-7.60	-2.70
Issuance of Common Equity	0.10	0.70	0.20	1.70	0.50	0.40	1.00	1.20
Other Financing Activities, net	-1.20	-1.70	-1.30	-2.30	-1.40	-1.00	-1.40	-2.90

This table presents Hippo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	1,643	1,569	1,525	1,543
Total Current Assets	841	627	287	365
Cash & Equivalents	776	195	142	198
Accounts Receivable	57	107	145	167
Plant, Property, & Equipment, net	0.00	0.00	162	206
Plant, Property & Equipment, gross	-	-	162	206
Total Noncurrent Assets	802	942	1,076	973
Long-Term Investments	55	121	187	168
Intangible Assets	58	66	76	65
Other Noncurrent Operating Assets	635	756	813	740
Total Liabilities & Shareholders' Equity	1,643	1,569	1,525	1,543
Total Liabilities	781	975	1,140	1,178
Total Current Liabilities	516	629	696	686
Accrued Expenses	95	128	114	87
Other Current Liabilities	420	501	583	599
Total Noncurrent Liabilities	265	346	444	492
Other Noncurrent Operating Liabilities	265	346	444	492
Commitments & Contingencies	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	862	594	385	365
Total Preferred & Common Equity	860	590	378	362
Total Common Equity	860	590	378	362
Common Stock	1,488	1,558	1,615	1,640
Retained Earnings	-628	-961	-1,234	-1,275
Accumulated Other Comprehensive Income / (Loss)	-0.70	-7.00	-2.90	-2.70
Noncontrolling Interest	2.10	3.60	6.80	3.10

This table presents Hippo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	9/30/2024
Total Assets	1,630	1,605	1,681	1,647	1,496	1,545
Total Current Assets	658	613	577	562	502	743
Cash & Equivalents	347	189	200	228	223	191
Restricted Cash	-	-	-	-	-	40
Short-Term Investments	222	290	229	189	125	354
Accounts Receivable	90	134	148	145	154	158
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	972	992	1,104	1,085	994	802
Intangible Assets	65	67	69	71	75	74
Other Noncurrent Operating Assets	798	784	899	873	757	728
Total Liabilities & Shareholders' Equity	1,630	1,605	1,681	1,647	1,496	1,545
Total Liabilities	991	1,062	1,234	1,236	1,142	1,215
Total Current Liabilities	661	687	798	776	705	710
Accrued Expenses	124	133	128	125	105	98
Other Current Liabilities	537	555	670	651	600	612
Total Noncurrent Liabilities	330	374	436	460	436	505
Other Noncurrent Operating Liabilities	330	374	436	460	436	505
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	639	543	447	411	355	330
Total Preferred & Common Equity	635	538	446	407	351	326
Total Common Equity	635	538	446	407	351	326
Common Stock	1,541	1,575	1,591	1,606	1,625	1,645
Retained Earnings	-898	-1,031	-1,139	-1,192	-1,270	-1,319
Accumulated Other Comprehensive Income / (Loss)	-7.80	-5.30	-6.40	-7.10	-3.40	0.50
Noncontrolling Interest	4.00	4.70	1.40	4.30	3.60	3.70

This table displays calculated financial ratios and metrics derived from Hippo's official financial filings.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-
Revenue Growth	76.74%	31.25%	75.19%	77.44%
EBITDA Growth	39.76%	-69.93%	22.08%	98.23%
EBIT Growth	30.99%	-52.21%	19.65%	89.56%
NOPAT Growth	-83.70%	-52.21%	19.65%	68.89%
Net Income Growth	-160.18%	11.25%	19.45%	89.13%
EPS Growth	-160.18%	57.02%	21.01%	85.84%
Operating Cash Flow Growth	-90.37%	-29.72%	42.79%	151.41%
Free Cash Flow Firm Growth	0.00%	38.97%	-78.76%	99.36%
Invested Capital Growth	124.56%	-312.22%	218.34%	-100.00%
Revenue Q/Q Growth	0.00%	3.28%	15.86%	0.00%
EBITDA Q/Q Growth	0.00%	1.11%	8.39%	0.00%
EBIT Q/Q Growth	0.00%	0.85%	7.35%	0.00%
NOPAT Q/Q Growth	0.00%	0.85%	7.35%	0.00%
Net Income Q/Q Growth	0.00%	-0.34%	7.43%	0.00%
EPS Q/Q Growth	0.00%	-1.10%	6.46%	0.00%
Operating Cash Flow Q/Q Growth	16.05%	-18.14%	-24.86%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	-218.07%	0.00%
Invested Capital Q/Q Growth	0.00%	-22.45%	137.73%	0.00%
Profitability Metrics	-	-	-	-
Gross Margin	-38.27%	-34.75%	-24.37%	19.97%
EBITDA Margin	-201.64%	-261.07%	-116.12%	-1.16%
Operating Margin	-236.07%	-273.77%	-125.56%	-22.01%
EBIT Margin	-236.07%	-273.77%	-125.56%	-7.39%
Profit (Net Income) Margin	-403.40%	-272.77%	-125.42%	-7.69%
Tax Burden Percent	100.19%	100.40%	100.19%	104.38%
Interest Burden Percent	170.55%	99.24%	99.70%	99.64%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	-4,286.28%	-206.59%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	-4,270.05%	-214.87%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	4,232.51%	198.97%
Return on Equity (ROE)	-73.07%	-44.87%	-53.77%	-7.63%
Cash Return on Invested Capital (CROIC)	-1,189.19%	0.00%	-516.59%	-6.59%
Operating Return on Assets (OROA)	-16.42%	-20.41%	-17.02%	-1.79%
Return on Assets (ROA)	-28.06%	-20.33%	-17.00%	-1.86%
Return on Common Equity (ROCE)	-47.89%	-44.70%	-53.20%	-7.53%
Return on Equity Simple (ROE_SIMPLE)	-42.80%	-55.35%	-69.60%	-7.90%
Net Operating Profit after Tax (NOPAT)	-151	-229	-184	-57
NOPAT Margin	-165.25%	-191.64%	-87.89%	-15.41%
Net Nonoperating Expense Percent (NNEP)	-40.41%	-13.12%	-16.23%	8.27%
Return On Investment Capital (ROIC_SIMPLE)	-	-38.65%	-47.91%	-15.70%
Cost of Revenue to Revenue	138.27%	134.75%	124.37%	80.03%
SG&A Expenses to Revenue	53.95%	59.73%	37.96%	19.00%
R&D to Revenue	39.69%	48.04%	22.41%	8.25%
Operating Expenses to Revenue	197.81%	239.01%	101.19%	41.98%
Earnings before Interest and Taxes (EBIT)	-215	-328	-263	-28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-184	-313	-244	-4.30
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	1.85	0.53	0.58	1.80
Price to Tangible Book Value (P/TBV)	2.13	0.60	0.72	2.20
Price to Revenue (P/Rev)	17.46	2.62	1.04	1.75
Price to Earnings (P/E)	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	34.16	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	8.28	0.00	0.00	0.78
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	6.11
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00
Financial Leverage	-1.07	-1.02	-0.99	-0.93
Leverage Ratio	2.60	2.21	3.16	4.09
Compound Leverage Factor	4.44	2.19	3.15	4.08
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.24%	0.61%	1.77%	0.85%
Common Equity to Total Capital	99.76%	99.39%	98.23%	99.15%
Debt to EBITDA	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00
Altman Z-Score	0.55	-1.28	-1.77	-0.89
Noncontrolling Interest Sharing Ratio	34.46%	0.39%	1.06%	1.32%
Liquidity Ratios	-	-	-	-
Current Ratio	1.63	1.00	0.41	0.53
Quick Ratio	1.63	1.00	0.41	0.53
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	-263	-160	-287	-1.83
Operating Cash Flow to CapEx	-882.98%	-819.80%	-197.86%	395.83%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-
Asset Turnover	0.07	0.07	0.14	0.24
Accounts Receivable Turnover	1.95	1.46	1.66	2.38
Inventory Turnover	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	2.03
Accounts Payable Turnover	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	187.30	249.58	219.66	153.12
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	187.30	249.58	219.66	153.12
Capital & Investment Metrics	-	-	-	-
Invested Capital	22	-47	56	0.00
Invested Capital Turnover	-2.69	-9.65	48.77	13.41
Increase / (Decrease) in Invested Capital	112	-69	102	-56
Enterprise Value (EV)	755	-323	-105	290
Market Capitalization	1,592	314	218	652
Book Value per Share	$1.53	$25.58	$15.82	$14.86
Tangible Book Value per Share	$1.33	$22.73	$12.65	$12.19
Total Capital	862	594	385	365
Total Debt	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00
Net Debt	-840	-640	-329	-365
Capital Expenditures (CapEx)	14	20	47	12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-459	-522	-551	-519
Debt-free Net Working Capital (DFNWC)	326	-2.60	-409	-321
Net Working Capital (NWC)	326	-2.60	-409	-321
Net Nonoperating Expense (NNE)	217	97	79	-29
Net Nonoperating Obligations (NNO)	-840	-640	-329	-365
Total Depreciation and Amortization (D&A)	31	15	20	23
Debt-free, Cash-free Net Working Capital to Revenue	-503.40%	-436.01%	-262.71%	-139.48%
Debt-free Net Working Capital to Revenue	357.02%	-2.17%	-194.95%	-86.37%
Net Working Capital to Revenue	357.02%	-2.17%	-194.95%	-86.37%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	($34.00)	($14.66)	($11.58)	($1.64)
Adjusted Weighted Average Basic Shares Outstanding	10.89M	22.75M	23.58M	24.70M
Adjusted Diluted Earnings per Share	($34.00)	($14.66)	($11.58)	($1.64)
Adjusted Weighted Average Diluted Shares Outstanding	10.89M	22.75M	23.58M	24.70M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	22.65M	23.31M	24.31M	25.08M
Normalized Net Operating Profit after Tax (NOPAT)	-151	-191	-180	-55
Normalized NOPAT Margin	-165.25%	-159.30%	-86.06%	-14.73%
Pre Tax Income Margin	-402.63%	-271.68%	-125.18%	-7.36%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-
Dividend Payout Ratio	0.00%	-1.62%	-3.65%	-71.33%
Augmented Payout Ratio	0.00%	-1.62%	-4.33%	-125.87%

This table displays calculated financial ratios and metrics derived from Hippo's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	9/30/2024
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	44.13%	11.88%	62.45%	66.20%	87.95%	80.17%	113.82%	100.21%
EBITDA Growth	-418.49%	3.47%	-1.28%	-46.33%	62.97%	40.51%	56.80%	100.70%
EBIT Growth	-326.85%	2.19%	-1.81%	-46.44%	60.22%	35.68%	51.26%	95.05%
NOPAT Growth	-126.51%	4.38%	-0.30%	-45.83%	60.25%	34.21%	51.26%	95.05%
Net Income Growth	-326.42%	-1.85%	-2.41%	-46.11%	60.55%	34.88%	51.40%	95.06%
EPS Growth	-326.42%	50.36%	0.00%	-41.85%	60.42%	35.02%	51.16%	92.62%
Operating Cash Flow Growth	14.00%	-467.92%	39.08%	68.79%	102.56%	-61.13%	149.58%	-13.98%
Free Cash Flow Firm Growth	102.37%	0.00%	-46.14%	-52.69%	3,250.68%	-597.67%	-16.35%	110.14%
Invested Capital Growth	-172.26%	-312.22%	-311.78%	-700.00%	-284.07%	218.34%	-101.81%	-116.92%
Revenue Q/Q Growth	6.97%	16.61%	11.17%	19.85%	20.96%	11.79%	31.94%	12.22%
EBITDA Q/Q Growth	-80.94%	52.59%	-10.68%	-57.91%	54.21%	23.85%	21.55%	102.56%
EBIT Q/Q Growth	-77.41%	50.86%	-10.47%	-55.56%	51.81%	20.55%	18.16%	84.19%
NOPAT Q/Q Growth	-76.81%	52.00%	-10.47%	-55.56%	51.81%	20.55%	18.16%	84.19%
Net Income Q/Q Growth	-77.08%	52.55%	-12.56%	-54.48%	52.19%	21.67%	15.99%	84.29%
EPS Q/Q Growth	-77.08%	51.06%	-8.66%	-53.16%	51.41%	19.64%	18.33%	76.87%
Operating Cash Flow Q/Q Growth	-44.30%	30.00%	-18.60%	73.95%	111.83%	-4,509.09%	136.49%	-159.89%
Free Cash Flow Firm Q/Q Growth	-98.37%	1,097.72%	153.72%	-4.28%	15.20%	-277.90%	-33.85%	140.45%
Invested Capital Q/Q Growth	-295.41%	-22.45%	-64.82%	-52.13%	-25.09%	137.73%	2.01%	-63.53%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	-28.66%	-10.34%	-34.42%	-100.21%	1.56%	14.73%	13.75%	22.30%
EBITDA Margin	-401.95%	-163.41%	-158.79%	-209.22%	-79.20%	-53.95%	-32.08%	0.73%
Operating Margin	-414.66%	-170.67%	-169.60%	-220.13%	-87.70%	-62.33%	-38.66%	-5.45%
EBIT Margin	-414.33%	-174.58%	-169.60%	-220.13%	-87.70%	-62.33%	-38.66%	-5.45%
Profit (Net Income) Margin	-415.31%	-168.99%	-171.11%	-220.55%	-87.18%	-61.09%	-38.90%	-5.45%
Tax Burden Percent	100.24%	100.83%	100.44%	100.19%	99.41%	100.77%	100.61%	100.00%
Interest Burden Percent	100.00%	96.00%	100.44%	100.00%	100.00%	97.26%	100.00%	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-4,577.03%	0.00%	0.00%	0.00%	0.00%	-2,127.62%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-4,572.01%	0.00%	0.00%	0.00%	0.00%	-2,125.30%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	4,528.44%	0.00%	0.00%	0.00%	0.00%	2,106.61%	0.00%	0.00%
Return on Equity (ROE)	-48.59%	-44.87%	-48.55%	-60.30%	-54.10%	-21.01%	-50.79%	-32.94%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	-516.59%	0.00%	0.00%
Operating Return on Assets (OROA)	-29.21%	-13.01%	-13.96%	-20.48%	-9.69%	-8.45%	-6.36%	-1.02%
Return on Assets (ROA)	-29.28%	-12.60%	-14.09%	-20.52%	-9.63%	-8.28%	-6.40%	-1.02%
Return on Common Equity (ROCE)	-48.39%	-44.70%	-48.26%	-60.11%	-53.67%	-20.78%	-50.32%	-32.73%
Return on Equity Simple (ROE_SIMPLE)	-51.24%	0.00%	-60.95%	-81.08%	-69.80%	0.00%	-64.92%	-39.22%
Net Operating Profit after Tax (NOPAT)	-89	-43	-47	-74	-35	-28	-23	-3.64
NOPAT Margin	-290.26%	-119.47%	-118.72%	-154.09%	-61.39%	-43.63%	-27.06%	-3.81%
Net Nonoperating Expense Percent (NNEP)	-5.02%	-2.40%	-2.99%	-4.89%	-2.41%	-2.32%	-1.78%	-0.27%
Cost of Revenue to Revenue	128.66%	110.34%	134.42%	200.21%	98.44%	85.27%	86.25%	77.70%
SG&A Expenses to Revenue	61.89%	49.72%	49.75%	45.07%	35.88%	27.29%	21.50%	16.02%
R&D to Revenue	48.21%	32.12%	29.15%	27.46%	20.62%	16.12%	9.75%	7.33%
Operating Expenses to Revenue	385.99%	160.34%	135.18%	119.92%	89.25%	77.05%	52.41%	27.75%
Earnings before Interest and Taxes (EBIT)	-127	-63	-68	-105	-51	-40	-33	-5.20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-123	-59	-63	-100	-46	-35	-27	0.70
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.67	0.53	0.70	0.86	0.46	0.58	1.26	1.29
Price to Tangible Book Value (P/TBV)	0.74	0.60	0.80	1.02	0.56	0.72	1.61	1.67
Price to Revenue (P/Rev)	3.66	2.62	2.80	2.50	1.04	1.04	1.74	1.39
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.99	-1.02	-1.03	-1.08	-1.18	-0.99	-1.26	-1.48
Leverage Ratio	2.13	2.21	2.43	2.76	3.12	3.16	3.45	4.15
Compound Leverage Factor	2.13	2.12	2.44	2.76	3.12	3.08	3.45	4.15
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.63%	0.61%	0.87%	0.31%	1.05%	1.77%	1.01%	1.12%
Common Equity to Total Capital	99.37%	99.39%	99.13%	99.69%	98.95%	98.23%	98.99%	98.88%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	-0.70	-0.72	-0.80	-1.03	-1.07	-1.29	-1.02	-0.78
Noncontrolling Interest Sharing Ratio	0.41%	0.39%	0.58%	0.31%	0.79%	1.06%	0.92%	0.66%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	1.00	1.00	0.89	0.72	0.72	0.41	0.71	1.05
Quick Ratio	1.00	1.00	0.89	0.72	0.72	0.41	0.71	0.99
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	2.19	26	67	64	73	-131	56	134
Operating Cash Flow to CapEx	-781.82%	-860.00%	-915.38%	-27.68%	23.40%	-1,077.78%	520.59%	-278.95%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.07	0.07	0.08	0.09	0.11	0.14	0.16	0.19
Accounts Receivable Turnover	1.54	1.46	1.39	1.43	1.54	1.66	1.77	1.98
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	236.35	249.58	263.07	254.55	237.15	219.66	205.69	184.43
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	236.35	249.58	263.07	254.55	237.15	219.66	205.69	184.43
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	-38	-47	-77	-118	-147	56	-156	-255
Invested Capital Turnover	15.77	-9.65	-6.62	-3.14	-1.95	48.77	-2.19	-1.62
Increase / (Decrease) in Invested Capital	-91	-69	-114	-137	-109	102	-79	-138
Enterprise Value (EV)	-249	-323	-237	-179	-365	-105	-63	-161
Market Capitalization	424	314	378	385	189	218	444	421
Book Value per Share	$1.11	$25.58	$23.10	$19.15	$17.20	$15.82	$14.45	$13.10
Tangible Book Value per Share	$1.00	$22.73	$20.22	$16.20	$14.22	$12.65	$11.36	$10.13
Total Capital	639	594	543	447	411	385	355	330
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-677	-640	-620	-565	-558	-329	-511	-585
Capital Expenditures (CapEx)	5.50	3.50	3.90	34	4.70	4.50	3.40	3.80
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-571	-522	-554	-650	-631	-551	-551	-553
Debt-free Net Working Capital (DFNWC)	-3.20	-2.60	-74	-221	-214	-409	-203	33
Net Working Capital (NWC)	-3.20	-2.60	-74	-221	-214	-409	-203	33
Net Nonoperating Expense (NNE)	38	18	21	32	15	11	10	1.56
Net Nonoperating Obligations (NNO)	-677	-640	-620	-565	-558	-329	-511	-585
Total Depreciation and Amortization (D&A)	3.80	4.00	4.30	5.20	4.90	5.40	5.60	5.90
Debt-free, Cash-free Net Working Capital to Revenue	-492.92%	-436.01%	-410.15%	-421.95%	-348.34%	-262.71%	-216.24%	-182.50%
Debt-free Net Working Capital to Revenue	-2.76%	-2.17%	-55.11%	-143.38%	-118.01%	-194.95%	-79.73%	10.77%
Net Working Capital to Revenue	-2.76%	-2.17%	-55.11%	-143.38%	-118.01%	-194.95%	-79.73%	10.77%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($5.66)	($2.77)	($3.01)	($4.61)	($2.24)	($1.80)	($1.47)	($0.34)
Adjusted Weighted Average Basic Shares Outstanding	22.84M	22.75M	23.20M	23.39M	23.73M	23.58M	24.23M	25.07M
Adjusted Diluted Earnings per Share	($5.66)	($2.77)	($3.01)	($4.61)	($2.24)	($1.80)	($1.47)	($0.34)
Adjusted Weighted Average Diluted Shares Outstanding	22.84M	22.75M	23.20M	23.39M	23.73M	23.58M	24.23M	25.07M
Adjusted Basic & Diluted Earnings per Share	$0.00	($2.77)	$0.00	$0.00	$0.00	($1.80)	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	23.06M	23.31M	23.26M	23.67M	23.89M	24.31M	24.43M	24.36M
Normalized Net Operating Profit after Tax (NOPAT)	-50	-43	-47	-74	-35	-24	-21	-9.38
Normalized NOPAT Margin	-164.17%	-119.47%	-118.72%	-154.09%	-61.39%	-37.66%	-24.10%	-9.82%
Pre Tax Income Margin	-414.33%	-167.60%	-170.35%	-220.13%	-87.70%	-60.62%	-38.66%	-5.45%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	-1.62%	0.00%	-2.63%	-3.38%	-3.65%	-7.28%	-10.55%
Augmented Payout Ratio	0.00%	-1.62%	-0.06%	-3.13%	-4.01%	-4.33%	-7.98%	-10.55%

Frequently Asked Questions About Hippo's Financials

When does Hippo's fiscal year end?

According to the most recent income statement we have on file, Hippo's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Hippo's net income changed over the last 3 years?

Hippo's net income appears to be on a downward trend, with a most recent value of -$28.60 million in 2024, falling from -$367.90 million in 2021. The previous period was -$263 million in 2023. See Hippo's forecast for analyst expectations on what’s next for the company.

What is Hippo's operating income?

Hippo's total operating income in 2024 was -$81.90 million, based on the following breakdown:

Total Gross Profit: $74.30 million
Total Operating Expenses: $156.20 million

How has Hippo revenue changed over the last 3 years?

Over the last 3 years, Hippo's total revenue changed from $91.20 million in 2021 to $372.10 million in 2024, a change of 308.0%.

How much debt does Hippo have?

Hippo's total liabilities were at $1.18 billion at the end of 2024, a 3.4% increase from 2023, and a 50.9% increase since 2021.

How much cash does Hippo have?

In the past 3 years, Hippo's cash and equivalents has ranged from $142.10 million in 2023 to $775.60 million in 2021, and is currently $197.60 million as of their latest financial filing in 2024.

How has Hippo's book value per share changed over the last 3 years?

Over the last 3 years, Hippo's book value per share changed from 1.53 in 2021 to 14.86 in 2024, a change of 873.0%.

Related Companies

This page (NYSE:HIPO) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hippo (HIPO) Financials

Frequently Asked Questions About Hippo's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hippo (HIPO) Financials

Annual Income Statements for Hippo

Quarterly Income Statements for Hippo

Annual Cash Flow Statements for Hippo

Quarterly Cash Flow Statements for Hippo

Annual Balance Sheets for Hippo

Quarterly Balance Sheets for Hippo

Annual Metrics and Ratios for Hippo

Quarterly Metrics and Ratios for Hippo

Frequently Asked Questions About Hippo's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools